AYTU
Aytu BioScience IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$28.55M
P/E Ratio
—
EPS
$-3.44
Beta
0.28
52W High
$3.06
52W Low
$0.96
50-Day MA
$2.52
200-Day MA
$2.36
Dividend Yield
—
Profit Margin
-39.00%
Forward P/E
3.69
PEG Ratio
0.00
About Aytu BioScience Inc
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.
Fundamentals
| Revenue (TTM) | $62.64M |
| Gross Profit (TTM) | $41.87M |
| EBITDA | $4.03M |
| Operating Margin | -13.00% |
| Return on Equity | -109.20% |
| Return on Assets | -0.22% |
| Revenue/Share (TTM) | $7.73 |
| Book Value | $1.32 |
| Price-to-Book | 2.03 |
| Price-to-Sales (TTM) | 0.46 |
| EV/Revenue | 0.314 |
| EV/EBITDA | 2.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -6.50% |
| Shares Outstanding | $10.73M |
| Float | $7.61M |
| % Insiders | 8.98% |
| % Institutions | 35.17% |
Analyst Ratings
Consensus ($9.67 target)
1
Strong Buy2
BuyData last updated: 4/7/2026